Medication delivery devices are provided having a housing comprising a reservoir sized sufficiently to hold medication, a dose button being rotatable relative to the housing to select a dose size of the medication for an injection, a printed circuit board, a switch mounted to the printed circuit board, and a controller in communication with the switch. The controller is configured to generate a first count of a set of signals using a first counting technique, generate a second count of the set of signals using a second counting technique, and determine, based on the first and second count, reliability data of the first and/or second count. The controller can connect, using a wireless communication module, to a remote computing device to wirelessly communicate with the remote computing device over an unencrypted wireless communication channel, and transmit, using the wireless communication module, encrypted data to the remote computing device.

A device for delivering a medication to a patient in a drug infusion system is disclosed. The device is configured as a fully autonomous and integrated wearable apparatus for managing the medication delivery. The device comprises: a reservoir for storing the medication to be delivered to the patient; a continuous glucose monitoring device for monitoring glucose levels in the patient to set flow rates for medication delivery; a needle for delivering the medication from reservoir into the patient; and a pumping unit including one or more MEMS devices configured to function as (a) a pump for pumping the medication from the reservoir through a flow path for medication to the needle at set flow rates and/or (b) a valve for regulating flow of the medication in the flow path from the reservoir through the needle.

Urine collection systems and associated methods and devices are disclosed herein. A representative system can include a urine collection device, a flow control assembly configured to direct a urine flow from the patient to the urine collection device, and a urine measurement device including a first sensor and a second sensor. The first sensor is configured to generate first sensor data based on a weight of the container, and the second sensor is configured to generate second sensor data based on the urine flow from the patient to the container. The system can further include non-transitory computer readable media having instructions that, when executed by one or more processors, cause the system to perform operations comprising determining a first patient urine output based on the first sensor data; and determining a second patient urine output based on the second sensor data.

Disclosed are apparatus and methods of detecting user interaction with a respiratory therapy device and effecting an action in response to the detection. The apparatus comprises a sensor which is positioned so as to detect the presence of a user's hand or fingers near to the apparatus, such as a surface or handle. In embodiments the apparatus may be configured to detect gestures or movement of the user. On detection of a user, the apparatus may be configured to effect one or more actions, such as disabling a feature of an input or output device or alerting a user.

A respiratory pressure therapy system for providing continuous positive air pressure to a patient via a patient interface configured to engage with at least one airway of the patient. The system includes: a flow generator configured to generate supply of breathable gas for delivery to the patient via the patient interface; at least one sensor; a display; and a computing device. The computing device is configured to: receive sensor data that is based on measured physical property of the supply of breathable gas; control, based on the received sensor data, the flow generator to adjust a property of the supply of breathable gas; receive, an input indicating assistance is needed with using the patient interface; receive one or more images of the patient with the patient interface; analyse the received one or more images; and based on the analysis, display instructions for positioning the patient interface.

Provided herein are dry powder formulations comprising epinephrine alone or in combination with at least one enabling agent suitable for nasal application. Also provided are unit dose forms and devices comprising such formulations and methods of using such formulations for the treatment of various conditions including anaphylaxis, anaphylactoid reaction, respiratory conditions, hemodynamic collapse, and for administration during cardiopulmonary arrest and other life-threatening conditions.

A system and method is provided for training operators (e.g., users), including new nurses or nephrologists as well as patients or their family members, to learn the intricacies of dialysis (e.g., hemodialysis) treatment through a simulation. The simulation may afford users the ability to fail catastrophically in simulated dialysis treatment, see the consequences, learn and internalize complex algorithms, and develop the ability to think in a time pressured situation. The simulation may thereby provide a safe learning environment for experiencing decisions and consequences of these decisions when performing a dialysis treatment. In some instances, the simulation may be in a mobile application form factor to encourage more ubiquitous use on personal devices, which may provide ease of access for the dialysis training. The simulation may further include time-based simulated scenarios that increase in difficulty and complexity between levels.

Disclosed are a computing apparatus, a computer-readable medium and a method that enable a user to use subjective inputs to alter settings of a wearable automatic drug delivery system. A user input device is presented on a graphical user interface that enables input of a subjective insulin need parameter. In response to receiving the input, the processor may modify a subjective coefficient value. A specific factor useable by an automatic insulin delivery algorithm is set based on the subjective coefficient value. Physiological condition data related to the user and the set specific factor may be used to determine a dosage of insulin to be delivered to the user based on the collected physiological condition data of the user. The processor may cause the determined dosage of insulin to be delivered to the user based on an output of the automatic insulin delivery algorithm.

A medical fluid pump, in particular a syringe pump, includes a housing and a drive head linearly movable toward the housing via a tubular or rod-shaped drive arm. The drive head has a drive head lower shell facing the housing and a drive head upper shell turned away from the housing. A metallic support structure in the form of a plate is accommodated in an interior space formed by the drive head lower shell and the drive head upper shell and is directly fixed to the drive head lower shell and to a free end portion of the tubular or rod-shaped drive arm.

A medical fluid pump of the infusion or syringe pump design includes a fluid pump housing which includes a display unit, in particular a display or touch display, with a plurality of display panels that are prepared and configured to display at least one respective function parameter of the fluid pump, including at least one setting parameter which can be set directly by a user of the fluid pump and a plurality of operating parameters which cannot be set directly by the user. The representation of the at least one setting parameter stands out visually against the operating parameters, such as by displaying the at least one setting parameter in an enlarged size compared to the operating parameters.